dostarlimab
gsk
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'i-spy 2', 'breast', 'i-spy', 'dostarlimab', 'paclitaxel', 'paclitaxel, oral', 'carboplatin']
 s dr.coral omene, &amp; colleagues present oral paclitaxel, carboplatin, and dostarlimab (ope/cb/d) without and with trastuzumab in early-stage, high-risk #breast cancer: results from the neoadjuvant i-spy 2 trial. at #asco23 (link below) 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.